Evidence map›Paper›PMID 41614519›Full record

Observational studyEuropean stroke journal2026

Intracranial haemorrhage without early clinical deterioration after mechanical thrombectomy: rethinking the "asymptomatic" label.

Christoph Riegler, Christian H Nolte, Regina von Rennenberg, Kerstin Bollweg, Marianne Hahn, Timo Uphaus, Anna Alegiani, Till Illies, Johannes Wischmann, Lars Kellert and 16 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in European stroke journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Christoph RieglerDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-2478-3500
Christian H NolteDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-5577-1775
Regina von RennenbergDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-3444-2045
Kerstin BollwegDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marianne HahnDepartment of Neurology, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0002-9462-3844
Timo UphausDepartment of Neurology, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0001-5526-0510
Anna AlegianiDepartment of Neurology, Asklepios Klinik Altona, Hamburg, Germany.
Till IlliesDepartment of Radiology and Neuroradiology, Asklepios Klinik Altona, Hamburg, Germany.ORCID 0009-0006-4563-6303
Johannes WischmannDepartment of Neurology, University Hospital LMU Munich, Munich, Germany.ORCID 0000-0003-0653-943X
Lars KellertDepartment of Neurology, University Hospital LMU Munich, Munich, Germany.ORCID 0000-0002-4967-8336
Kathleen BernkopfDepartment of Neurology, School of Medicine Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Silke WunderlichDepartment of Neurology, School of Medicine Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Florian HennersdorfDepartment of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany.
Sven PoliDepartment of Neurology and Stroke, Tübingen University Hospital, Tübingen, Germany.ORCID 0000-0002-0286-8781
Leonhard MannDepartment of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Fee KeilDepartment of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-9158-1538
Ala JamousInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University Göttingen, Göttingen, Germany.ORCID 0000-0002-8890-2150
Marielle-Sophie ErnstInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University Göttingen, Göttingen, Germany.
Franziska BürkleDepartment of Diagnostic and Interventional Neuroradiology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0009-0002-9462-6460
Martin WiesmannDepartment of Diagnostic and Interventional Neuroradiology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-8261-5513
Burakhan AkkurtDepartment of Radiology, Neuroendovascular Program, University Medical Center Münster, Münster, Germany.
Tobias FaizyDepartment of Radiology, Neuroendovascular Program, University Medical Center Münster, Münster, Germany.ORCID 0000-0002-1631-2020
Heinrich J AudebertDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-4785-0366
Mike P WattjesDepartment of Neuroradiology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-9298-2897
Eberhard SiebertDepartment of Neuroradiology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-7395-6546
Jawed NawabiDepartment of Neuroradiology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-1137-0643

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionICH is a common complication following endovascular therapy (EVT) for ischaemic stroke. While sICH is known to worsen outcomes, the impact of ICH without early neurological deterioration (END), commonly referred to as "asymptomatic" (aICH), remains controversial. This study aimed to assess imaging patterns of aICH and its effect on clinical outcomes. PATIENTS AND

methodsThis study used data from the prospective, multicentre German Stroke Registry-Endovascular Treatment. Bleedings were assessed on follow-up imaging at 24 hours applying the Heidelberg Bleeding Classification. European Cooperative Acute Stroke Study III (ECASS)-III criteria were used to stratify patients into (1) no ICH, (2) aICH and (3) sICH. The primary outcome was functional independence (mRS ≤ 2) at 3 months. Secondary outcomes included mRS shift and 3-month mortality.

resultsAmong 4834 patients with EVT (median age 76, 51% female, median NIHSS 14), ICH occurred in 13.2% (aICH: 9.7%, sICH: 3.5%). Haemorrhage patterns differed, with sICH being more often parenchymal (48.2% vs 34.6%), multicompartmental (34.1% vs 20.2%) and involving the ventricular system (18.8% vs 7.6%), while aICH were predominantly haemorrhagic transformation (34.6% vs 21.8%). Functional independence at 90 days was reached by 40.0% (no ICH), 25.4% (aICH; adjusted odds ratio [aOR] 0.43 [0.32-0.58]) and 6.5% (sICH; aOR 0.06 [0.03-0.14]), respectively. aICH was associated with worse overall recovery (mRS shift adjusted common OR 0.51 [0.41-0.63]) and higher 90-day mortality (35.5% vs 24.9%; aOR 1.90 [1.44-2.51]), when compared to no ICH.

conclusionICH after EVT was associated with worse functional recovery and higher mortality, even in the absence of END. Given these results, the term "asymptomatic ICH" warrants reconsideration.

Indexed as

Endovascular ProceduresIntracranial HemorrhagesIschemic StrokeThrombectomyAgedAged, 80 and overFemaleHumansMaleProspective StudiesRegistriesTreatment Outcome(asymptomatic) ICHendovascular therapyhaemorrhagic transformationischaemic strokemechanical thrombectomy

Identifiers

PMID41614519
PMCPMC12866645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.